Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research 2026: Market Size, Trends, Segments And Growth Forecast
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Revenue Growth On Track For A 23.3% CAGR Through 2030
The artificial intelligence (AI)-powered clinical trial site feasibility market size has experienced significant growth in recent years. This market is projected to increase from $1.53 billion in 2025 to $1.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. Historically, this expansion has been attributed to the increasing complexity of clinical trial designs, rising cost pressures on drug development timelines, a growing reliance on data-driven trial planning, the expansion of global multi-site clinical trials, and the early adoption of predictive analytics in trial feasibility.
The artificial intelligence (AI)-powered clinical trial site feasibility market is anticipated to undergo significant expansion in the upcoming years, with projections indicating it will reach $4.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 23.3%. This growth in the forecast period is fueled by the increasing adoption of decentralized clinical trials, a rising demand for faster site activation, the growing utilization of real-world evidence in feasibility decisions, the expansion of AI-enabled trial planning platforms, and a heightened emphasis on trial risk mitigation. Prominent trends for the forecast period encompass the increasing embrace of AI-driven site selection models, a rising use of predictive patient recruitment analytics, the growing integration of real-world data in feasibility assessment, the expansion of cloud-based feasibility platforms, and an enhanced focus on trial performance forecasting.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Growth Momentum: What Factors Are Shaping Demand?
The anticipated expansion in clinical trials is set to propel the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market going forward. Clinical trials refer to global clinical research studies conducted to assess the safety and efficacy of new medical treatments, drugs, and devices. The increasing number of clinical trials is largely influenced by rising investment in biomedical research and development, as both governmental and private sectors recognize the critical need for innovative treatments to address evolving healthcare challenges. This expansion of clinical trials creates demand for AI-powered site feasibility tools because research organizations require efficient systems to identify optimal locations, evaluate site capabilities, and predict enrollment success rates for their studies. For instance, in April 2025, according to the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, the total number of interventional clinical trials, hereafter referred to as clinical trials, available on the clinicaltrials.gov webpage was 404,637. Therefore, the growth in clinical trials is driving the expansion of the artificial intelligence (AI)-powered clinical trial site feasibility market.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segment Analysis And Revenue Potential
The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software
2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends Redefining Industry Growth
Major companies operating in the artificial intelligence-powered clinical trial site feasibility market are concentrating on developing advanced solutions, such as an AI-driven feasibility and recruitment platform, to refine site selection and elevate overall operational efficiency in clinical trials. Such a platform is a software solution that leverages artificial intelligence and machine learning to analyze trial protocols and site data, with the goal of identifying optimal clinical sites and improving patient recruitment by efficiently matching eligible participants, thereby accelerating trial timelines and boosting study success. For example, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen, an artificial intelligence-powered feasibility and recruitment platform designed to optimize clinical trial performance. This is achieved by enhancing patient identification, prequalification, and retention through real-time integration with electronic health records (EHRs) and the utilization of AI and machine learning algorithms. The platform empowers clinical trial sites to connect directly with patient data, stratify health risks, and pinpoint the most qualified candidates to expedite enrollment and improve trial outcomes.
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Key Players Shaping Industry Direction
Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI
View The Full Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:
Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
